January 21, 2025 - 16:16

President Donald Trump has signed an executive order to withdraw the United States from the World Health Organization (WHO), citing its handling of the COVID-19 pandemic as a primary reason for this significant decision. The move is expected to halt millions of dollars in funding that the U.S. previously allocated to the global health body.
Critics of the decision argue that this withdrawal could undermine international efforts to combat the pandemic and address other pressing health issues. The WHO has been at the forefront of coordinating global responses to health crises, and losing U.S. support may hinder its ability to operate effectively.
The administration's decision has sparked a heated debate about the role of international organizations in public health and the importance of global cooperation in fighting diseases. As the world continues to grapple with the impacts of COVID-19, the implications of this withdrawal remain to be seen, with many experts warning of potential long-term consequences for global health initiatives.
February 8, 2026 - 21:58
4 Dead in Mushroom Poisoning Outbreak in CaliforniaA deadly outbreak of mushroom poisoning has resulted in four fatalities in California, prompting urgent warnings from public health authorities. The tragic incidents are believed to be linked to...
February 8, 2026 - 07:43
Oklahomans lose health care coverage as INTEGRIS Health, United Healthcare fail to reach agreementA critical contract dispute between INTEGRIS Health and United Healthcare has culminated in a widespread loss of in-network coverage for many Oklahoma patients. The two major healthcare entities...
February 7, 2026 - 18:27
Cladribine Tablets Reduce Treatment Switches, Outpatient Visits, and Health Care Costs in Multiple Sclerosis | NeurologyLive - Clinical Neurology News and Neurology Expert InsightsA recent real-world study has provided compelling evidence for the effectiveness of cladribine tablets in treating multiple sclerosis (MS). The research indicates that patients initiating treatment...
February 7, 2026 - 05:48
Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug dataFollowing the release of encouraging new data for its twice-daily experimental pill, danuglipron, Pfizer has moved decisively to chart its future strategy in the lucrative obesity treatment arena....